These results suggest that despite both drugs demonstrating on-target signaling alterations, MEK but not mTOR inhibition consistently reduces tumor cell proliferation and induces tumor cell apoptosis in MOC tumors in vivo. The gene discussed is MAP2K7; the disease is neoplasm.